These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32654422)

  • 1. Use of tocilizumab in kidney transplant recipients with COVID-19.
    Pérez-Sáez MJ; Blasco M; Redondo-Pachón D; Ventura-Aguiar P; Bada-Bosch T; Pérez-Flores I; Melilli E; Sánchez-Cámara LA; López-Oliva MO; Canal C; Shabaka A; Garra-Moncau N; Martín-Moreno PL; López V; Hernández-Gallego R; Siverio O; Galeano C; Espí-Reig J; Cabezas CJ; Rodrigo MT; Llinàs-Mallol L; Fernández-Reyes MJ; Cruzado-Vega L; Pérez-Tamajón L; Santana-Estupiñán R; Ruiz-Fuentes MC; Tabernero G; Zárraga S; Ruiz JC; Gutiérrez-Dalmau A; Mazuecos A; Sánchez-Álvarez E; Crespo M; Pascual J;
    Am J Transplant; 2020 Nov; 20(11):3182-3190. PubMed ID: 32654422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.
    Morillas JA; Marco Canosa F; Srinivas P; Asadi T; Calabrese C; Rajendram P; Budev M; Poggio ED; Narayanan Menon KV; Gastman B; Koval C
    Am J Transplant; 2020 Nov; 20(11):3191-3197. PubMed ID: 32476261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.
    Pereira MR; Aversa MM; Farr MA; Miko BA; Aaron JG; Mohan S; Cohen DJ; Husain SA; Ratner LE; Arcasoy S; Uriel N; Zheng EX; Fox AN; Tsapepas DS; Emond JC; Verna EC
    Am J Transplant; 2020 Nov; 20(11):3198-3205. PubMed ID: 32946668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in elderly kidney transplant recipients.
    Crespo M; Pérez-Sáez MJ; Redondo-Pachón D; Llinàs-Mallol L; Montero MM; Villar-García J; Arias-Cabrales C; Buxeda A; Burballa C; Vázquez S; López T; Moreno F; Mir M; Outón S; Sierra A; Collado S; Barrios C; Rodríguez E; Sans L; Barbosa F; Cao H; Arenas MD; Güerri-Fernández R; Horcajada JP; Pascual J
    Am J Transplant; 2020 Oct; 20(10):2883-2889. PubMed ID: 32471001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients.
    Ringer M; Azmy V; Kaman K; Tang D; Cheung H; Azar MM; Price C; Malinis M
    Transpl Infect Dis; 2021 Apr; 23(2):e13556. PubMed ID: 33378571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.
    Bossini N; Alberici F; Delbarba E; Valerio F; Manenti C; Possenti S; Econimo L; Maffei C; Pola A; Terlizzi V; Salviani C; Moscato M; Pasquali S; Zambetti N; Tonoli M; Affatato S; Pecchini P; Viola FB; Malberti F; Depetri G; Gaggiotti M; Scolari F;
    Am J Transplant; 2020 Nov; 20(11):3019-3029. PubMed ID: 32627319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.
    Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F
    J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
    Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
    Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in lung transplant recipients: A single center case series from New York City.
    Aversa M; Benvenuto L; Anderson M; Shah L; Robbins H; Pereira M; Scheffert J; Carroll M; Hum J; Nolan M; Reilly G; Lemaitre P; Stanifer BP; D'Ovidio F; Sonett J; Arcasoy S;
    Am J Transplant; 2020 Nov; 20(11):3072-3080. PubMed ID: 32881315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is COVID-19 infection more severe in kidney transplant recipients?
    Caillard S; Chavarot N; Francois H; Matignon M; Greze C; Kamar N; Gatault P; Thaunat O; Legris T; Frimat L; Westeel PF; Goutaudier V; Jdidou M; Snanoudj R; Colosio C; Sicard A; Bertrand D; Mousson C; Bamoulid J; Masset C; Thierry A; Couzi L; Chemouny JM; Duveau A; Moal V; Blancho G; Grimbert P; Durrbach A; Moulin B; Anglicheau D; Ruch Y; Kaeuffer C; Benotmane I; Solis M; LeMeur Y; Hazzan M; Danion F;
    Am J Transplant; 2021 Mar; 21(3):1295-1303. PubMed ID: 33259686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.
    Price CC; Altice FL; Shyr Y; Koff A; Pischel L; Goshua G; Azar MM; Mcmanus D; Chen SC; Gleeson SE; Britto CJ; Azmy V; Kaman K; Gaston DC; Davis M; Burrello T; Harris Z; Villanueva MS; Aoun-Barakat L; Kang I; Seropian S; Chupp G; Bucala R; Kaminski N; Lee AI; LoRusso PM; Topal JE; Dela Cruz C; Malinis M
    Chest; 2020 Oct; 158(4):1397-1408. PubMed ID: 32553536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.
    Morrison AR; Johnson JM; Griebe KM; Jones MC; Stine JJ; Hencken LN; To L; Bianchini ML; Vahia AT; Swiderek J; Ramesh MS; Peters MA; Smith ZR
    J Autoimmun; 2020 Nov; 114():102512. PubMed ID: 32646770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?
    Ghaffari Rahbar M; Nafar M; Khoshdel A; Dalili N; Abrishami A; Firouzan A; Poorrezagholi F; Samadian F; Ziaie S; Fatemizadeh S; Samavat S
    Transpl Infect Dis; 2020 Oct; 22(5):e13406. PubMed ID: 32654357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region.
    Maritati F; Cerutti E; Zuccatosta L; Fiorentini A; Finale C; Ficosecco M; Cristiano F; Capestro A; Balestra E; Taruscia D; Vivarelli M; Donati A; Perna GP; Giacometti A; Tavio M; Onesta M; Di Sante L; Ranghino A
    Transpl Infect Dis; 2020 Oct; 22(5):e13377. PubMed ID: 32573895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain.
    Loinaz C; Marcacuzco A; Fernández-Ruiz M; Caso O; Cambra F; San Juan R; Justo I; Calvo J; García-Sesma A; Manrique A; Pérez-Jacoiste Asín MA; Folgueira MD; Aguado JM; Lumbreras C
    Transpl Infect Dis; 2020 Oct; 22(5):e13372. PubMed ID: 32562561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
    Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
    Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
    Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P
    Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.